Sponsor:
Amgen
Code:
NCT04521231
Conditions
B Cell Precursor Acute Lymphoblastic Leukemia
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Blinatumomab
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations